Home
>
National Drug Code (NDC)
>
Protonix
Protonix - 0008-0844-02 - (PANTOPRAZOLE SODIUM)
Drug Information of Protonix
| Product NDC: | 0008-0844 |
| Proprietary Name: | Protonix |
| Non Proprietary Name: | PANTOPRAZOLE SODIUM |
| Active Ingredient(s): | 40 mg/1 & nbsp; PANTOPRAZOLE SODIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | GRANULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Protonix
| Product NDC: | 0008-0844 |
| Labeler Name: | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022020 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080229 |
Package Information of Protonix
| Package NDC: | 0008-0844-02 |
| Package Description: | 30 PACKET in 1 CARTON (0008-0844-02) > 1 GRANULE, DELAYED RELEASE in 1 PACKET (0008-0844-01) |
NDC Information of Protonix
| NDC Code | 0008-0844-02 |
| Proprietary Name | Protonix |
| Package Description | 30 PACKET in 1 CARTON (0008-0844-02) > 1 GRANULE, DELAYED RELEASE in 1 PACKET (0008-0844-01) |
| Product NDC | 0008-0844 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PANTOPRAZOLE SODIUM |
| Dosage Form Name | GRANULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080229 |
| Marketing Category Name | NDA |
| Labeler Name | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Substance Name | PANTOPRAZOLE SODIUM |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
